S&P ASX All Technology

US Dollar vs AUD

Register for real-time alerts, custom portfolio, and market movers

Get Started

AMPH Amphastar Pharmaceuticals Inc

40.01

1.36 (3.52%)

20 Apr 2024 - Closed

Delayed by 15 minutes

Amphastar receives FDA tentative approval for Vasopressin

To read the full story on Seeking Alpha, click here.

Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more Amphastar Pharmaceuticals Charts.

Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more Amphastar Pharmaceuticals Charts.

Amphastar Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Saturday 10 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 3 February 2024 (3 months ago) • Edgar (US Regulatory)

More Amphastar Pharmaceuticals Inc News Articles

National Australia Bank

Australian SE All Ordina...

Verizon Communications

S&P ASX 300 Metals and M...

Woodside Petroleum

Newcrest Mining

Westpac Banking

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions